摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3-(4-chlorophenyl)-5-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide

中文名称
——
中文别名
——
英文名称
4-(3-(4-chlorophenyl)-5-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide
英文别名
4-[5-(4-Chlorophenyl)-3-naphthalen-2-yl-3,4-dihydropyrazol-2-yl]benzenesulfonamide;4-[5-(4-chlorophenyl)-3-naphthalen-2-yl-3,4-dihydropyrazol-2-yl]benzenesulfonamide
4-(3-(4-chlorophenyl)-5-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide化学式
CAS
——
化学式
C25H20ClN3O2S
mdl
——
分子量
461.972
InChiKey
BDBAYMZOFMAWRY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    32
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    84.1
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    1-(4-chlorophenyl)-3-(2-naphthalenyl)prop-2-en-1-one4-磺酰胺基苯肼盐酸盐溶剂黄146 作用下, 以 乙醇 为溶剂, 以71.3%的产率得到4-(3-(4-chlorophenyl)-5-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide
    参考文献:
    名称:
    Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis
    摘要:
    New series of sulfonamide derivatives containing a dihydropyrazole moieties inhibitors of MMP-2/MMP-9 were discovered using structure-based drug design. Synthesis, antitumor activity, structure-activity relationship and optimization of physicochemical properties were described. In vitro the bioassay results revealed that most target compounds showed potent inhibitory activity in the enzymatic and cellular assays. Among the compounds, compound 3i exhibited the most potent inhibitory activity with IC50 values of 0.21 mu M inhibiting MMP-2 and 1.87 mu M inhibiting MMP-9, comparable to the control positive compound CMT-1 (1.26 mu M, 2.52 mu M). Docking simulation was performed to position compound 3i into the MMP-2 active site to determine the probable binding pose. Docking simulation was further performed to position compound 3i into the MMP-2 active site to determine the probable binding model the 3D-QSAR models were built for reasonable design of MMP-2/MMP-9 inhibitors at present and in future. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2015.08.026
点击查看最新优质反应信息

文献信息

  • Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis
    作者:Xiao-Qiang Yan、Zhong-Chang Wang、Zhen Li、Peng-Fei Wang、Han-Yue Qiu、Long-Wang Chen、Xiao-Yuan Lu、Peng-Cheng Lv、Hai-Liang Zhu
    DOI:10.1016/j.bmcl.2015.08.026
    日期:2015.10
    New series of sulfonamide derivatives containing a dihydropyrazole moieties inhibitors of MMP-2/MMP-9 were discovered using structure-based drug design. Synthesis, antitumor activity, structure-activity relationship and optimization of physicochemical properties were described. In vitro the bioassay results revealed that most target compounds showed potent inhibitory activity in the enzymatic and cellular assays. Among the compounds, compound 3i exhibited the most potent inhibitory activity with IC50 values of 0.21 mu M inhibiting MMP-2 and 1.87 mu M inhibiting MMP-9, comparable to the control positive compound CMT-1 (1.26 mu M, 2.52 mu M). Docking simulation was performed to position compound 3i into the MMP-2 active site to determine the probable binding pose. Docking simulation was further performed to position compound 3i into the MMP-2 active site to determine the probable binding model the 3D-QSAR models were built for reasonable design of MMP-2/MMP-9 inhibitors at present and in future. (C) 2015 Elsevier Ltd. All rights reserved.
查看更多